|
Guido J. Neels became a director of Biopure in August 2005. From July 2004 until retiring in November 2005, Neels served as chief operating officer of Guidant Corporation, a world leader in the development of cardiovascular medical products. He is responsible for the global operations of Guidant's four operating units: Cardiac Rhythm Management, Vascular Intervention, Cardiac Surgery, and Endovascular Solutions. From December 2002 to July 2004, he was group chairman, Office of the President, responsible for worldwide sales operations, corporate communications, corporate marketing, investor relations and government relations. In January 2000, he was named president, Europe, Middle East, Africa and Canada. He previously served as vice president of global marketing for Vascular Intervention and as managing director for German and Central European operations.
From 1982 until Guidant was spun off as an independent public company from Eli Lilly and Co. in 1994, Neels held various general management and sales and marketing positions at Lilly in Europe and the U.S. From 1972 to 1980, he held positions in information technology, finance and manufacturing at Raychem Corporation in Belgium and the U.S.
Neels is a director of the New England Healthcare Institute, a non-profit, applied research health policy organization. He holds a M.B.A. degree from Stanford University and a business engineering degree from the University of Leuven in Belgium. | 